(-)-Blebbistatin (S-(-)-Blebbistatin)
(-)-Blebbistatin 是选择性的非肌肉肌球蛋白 II (myosin II) ATPase 活性的抑制剂。
-
货号:
TK0297 -
规格:
- 1mg
- 2mg
- 5mg
- 10mg
-
价格:
¥0.00
(-)-Blebbistatin 是选择性的非肌肉肌球蛋白 II (myosin II) ATPase 活性的抑制剂。
| CAS No. | 856925-71-8 |
| 生物活性 | (-)-Blebbistatin is a selective inhibitor of the ATPase activity of non-muscle myosin II. |
| 分子式 | C18H16N2O2 |
| 分子量 | 292.33 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | 4°C, stored under nitrogen |
| 溶解性数据 | DMSO : 10 mg/mL (34.21 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) |
| 体内研究 | Blebbistatin dose-dependently and completely relax both KCl- and carbachol-induced rat detrusor and endothelin-1-induced human bladder contraction. Pre-incubation with 10 μM blebbistatin attenuates carbachol responsiveness by 65% while blocking electrical field stimulation-induced bladder contraction reaching 50% inhibition at 32 Hz. |
| 体外研究 | Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 values ranging from 0.5 to 5 μM. Smooth muscle myosin is only poorly inhibited (IC50=80 μM). Blebbistatin does not compete with nucleotide binding to the skeletal muscle myosin subfragment-1. The inhibitor preferentially binds to the ATPase intermediate with ADP and phosphate bound at the active site, and it slows down phosphate release. It blocks the myosin heads in a products complex with low actin affinity. In culture-activated hepatic stellate cells, blebbistatin is found to change both cell morphology and function. Stellate cells become smaller, acquire a dendritic morphology and have less myosin IIA-containing stress fibres and vinculin-containing focal adhesions. Blebbistatin impairs silicone wrinkle formation, reduces collagen gel contraction and blocks endothelin-1-induced intracellular Ca release. It promotes wound-induced cell migration. |
| 文献 | •Adv Sci (Weinh). 2020 Jun 17;7(15):1903583. •Theranostics. 2019 Apr 13;9(9):2555-2571. •J Cell Biol. 2021 Oct 4;220(10):e202010118. •Anal Chem. 2017 Oct 17;89(20):10841-10849. •Nanomedicine (Lond). 2019 Mar;14(5):613-626. •Colloids Surf B Biointerfaces. 2019 Oct 1;182:110332. •Am J Physiol Heart Circ Physiol. 2021 Jul 2. •Fundamental Research. 23 December 2021. |
| 纯度及产品资料 | 98% |